Neurable Opens Its BCI Platform to OEMs, Backed by a Fully Built Leadership Bench
The signal is getting louder, and this time it is not coming from your phone, your watch, or your inbox. It is coming from your head. Boston-based Neurable Inc., founded in 2015, is stepping out of the lab and into the licensing arena, opening its noninvasive brain-computer interface technology to external builders with intent that lands squarely inside today’s tech news cycle. Not someday. Not in theory. Now. And according to the company, what comes next is not incremental. It is a surge of third-party hardware expected across 2026 and 2027.
Dr. Ramses Alcaide, Co-Founder and CEO, remains the constant, translating years of neuroscience research into commercial form. Alongside him, Adam Molnar, Co-Founder and newly appointed COO, steps into operational command, shifting from partnerships into full-scale execution. This is not a light reshuffle. It is a signal that Neurable is preparing to move volume, not just vision.
The bench behind them fills in the intent. Reid Van Gorder joins as CFO, bringing capital discipline as the company scales its licensing engine. Eugene Goldberg steps in as VP of Business Development, tasked with turning OEM interest into signed integrations. James Flynn, now VP of Product, carries the responsibility of translating a complex neurotechnology stack into something partners can actually ship. Jessica Randazza-Pade, VP of Marketing and Communications, owns the narrative layer, where education and adoption meet. Lindsay Nie, VP of Engineering, anchors the technical backbone, ensuring the system holds as it stretches across devices and partners.
Beyond the core executive layer, the build continues. Avi Horowitz, Head of Product for Defense, signals expansion into regulated and high-stakes environments. Dr. Alicia Howell-Munson, Research Scientist, represents the ongoing pipeline from lab insight to product reality. And at the governance level, Paul Leggett of Mithril Capital Management and Dr. Luis Sentis of Apptronik join the Board of Directors, bringing capital perspective and deep technical credibility into the room where long-term decisions get made.
The strategy they are executing is clean. Neurable is no longer just building hardware. It is becoming the intelligence layer inside other companies’ products. Headphones, glasses, headbands, hats, all becoming vessels for EEG-based sensing that reads focus, fatigue, and cognitive load in real time. The MW75 Neuro headphones with Master and Dynamic in September 2024 proved the system works. The HyperX gaming headset moment at CES 2026 proved it translates across categories. Now comes distribution.
Capital supports the move. A $35M Series A in December 2025, bringing total funding to roughly $65M, gave Neurable the runway to shift from precision to proliferation. The licensing model removes the constraint of building every device in-house and replaces it with scale through partners. It is a familiar pattern in tech news, but rarely applied this directly to the human brain.
The risks are real. Cognitive data introduces a new layer of privacy scrutiny. Platform consistency across OEM implementations will test execution. And consumer adoption will depend on whether insight becomes habit. But Neurable is not presenting this as novelty. It is presenting it as awareness, operationalized.
If the structure holds, this is not a single-company story. It is the emergence of a category layer, one that sits quietly inside devices and speaks in signals most people have never seen before. And as this model spreads, the question shifts from whether the technology works to how far it reaches, a question that will keep echoing across tech news as more devices start listening to something deeper than clicks and taps.